Tag Archives: medical polymer markets

NanoMarkets Announces Release of New Report, “Worldwide Medical Polymer Markets 2013-2020”

The report titled, “Worldwide Medical Polymer Markets 2013-2020” identifies the current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising.

Glen Allen, Virginia (September 19, 2013) — According to a new report from industry analyst firm NanoMarkets, the global medical polymer market will grow from $2.3 billion (USD) in 2013 to over $3.5 billion in 2018. The report titled, “Worldwide Medical Polymer Markets 2013-2020” identifies the current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising.

The report also includes granular eight-year forecasts and an analysis of the complete supply chain for medical polymers. Firms addressed within the report include, Bayer MaterialScience, Celanese, Dow Corning, Dow Chemical, DSM, DuPont, Eastman Chemical, Evonik, Solvay and others.

Details about the report are available at: http://nanomarkets.net/market_reports/report/worldwide_medical_polymer_markets_2013_2020.

From the Report:

Implants currently consume about half the medical polymers produced and are expected to account for around $1.6 billion in polymer sales by 2018. Polymers have been penetrating the implant market because they are lower cost and lighter weight than metal alternatives, such as titanium. The report also indicates that increased use of medical imaging is creating further demand for polymers.

According to the new NanoMarkets report, sales of polymers for diagnostic systems will reach $1.04 billion in 2018. In vitro diagnostics account for 50,000 to 60,000 metric tons of specialized and commodity plastics every year. Most diagnostic procedures today are rapid, multi-assays, and plastics have become indispensable. The growth prospects in this sector are thus particularly strong.

The report claims that PMMA, PS/styrenics, and PP are the leading medical polymers based on revenue accounting for around 26 percent of the market in 2013. There are also some high-value niches appearing in the market. Commercial elastomers that provide a “soft touch” are being used to coat accessories, such as catheters, gloves, and syringes, in order to impart a soft touch feel. Their use is expected to grow in intravenous drug delivery systems, cardio systems, and blood collection devices.

The last decade has seen the rise of biodegradable polymers. The current trend suggests that in the near future, entire prostheses will be developed from these materials. While they will not be used to manufacture diagnostic products, biodegradable polymers will be incorporated into implants and some clinical labware. There is some additional interest in discovering new biodegradable polymers for medical applications, but investment in this area is limited due to the need to complete extensive long-term studies in order to validate new materials.

About the Report:

This new report provides the necessary strategic insight into how the polymer industry can best generate new business revenues in medical applications and where the medical device industry can expect polymer materials to make their greatest impact. This report which polymers are likely to do best in the medical environment. This study also contains detailed eight-year forecasts in volume (Kg) and value terms.

Readers of this report will gain the following:

• An analytical review of polymers used for medical applications, including developing implants, diagnostic systems, and hospital labware.

• Knowledge on current technical and market trends, including general market drivers for improvement in the healthcare sector, polymer production, and evaluation for clinical approval.

• An understanding of key medical products and their future implications.

• A pin-pointed analysis of the changing dynamics of polymer producers.

• Eight–year forecasts based on expected market growth.

• A brief technological road map for understanding industry growth.

• Profiles of major companies operating as manufacturers of medical polymers.

• Insight into important geographical locations pertaining to polymer and healthcare sectors.

• Information on the size of the medical polymer market in developed nations and the fast-growing economies in Asia, such as China and India.

• Details of the regulatory requirements of these countries for producing high-quality, medically approved polymers and their use in various applications.

• Help in making business decisions for venturing into the medical polymer market.

• Descriptive and distinctive graphics, along with concise, tabular analyses of various domains.

About NanoMarkets:

NanoMarkets tracks and analyzes emerging markets in medical, energy, electronics and other area created by developments in advanced materials. The firm is a recognized leader in industry analysis and forecasts of in the transparent conductor industry.

Visit http://www.nanomarkets.net for a full listing of NanoMarkets’ reports and other services.

Media Contact:
Robert Nolan
NanoMarkets, LC
PO BOX 3840
Glen Allen, VA 23058
(804) 938-0030
rob@nanomarkets.net
http://www.nanomarkets.net

NanoMarkets Announces Upcoming Report “Worldwide Medical Polymer Markets 2013-2020” To Publication Schedule

NanoMarkets today announced the addition of a new report to its schedule titled, “Worldwide Medical Polymer Markets 2013-2020” that will be release in late August of 2013.

Glen Allen, Virginia (August 9, 2013) — Industry Analyst firm NanoMarkets today announced the addition of a new report to its schedule titled, “Worldwide Medical Polymer Markets 2013-2020” that will be release in late August of 2013. Details about the report are available at: http://nanomarkets.net/market_reports/report/worldwide_medical_polymer_markets_2013_2020.

About the Report:
NanoMarkets believes that medical polymers represents a major opportunity in the medical materials market over the next few years. Several factors are leading to growth in this market. Perhaps the most obvious is the aging of the population in developed nations is expanding the addressable market for polymer implants. Many polymer implants are specifically intended to assist elder patients.

Opportunity in this market has also expanded because the latest technical developments in medical polymers can fine tune implant capabilities, enable better fits for implants, and increased biocompatibility. Polymer structures can also now substitute for cartilage or enable doctors to grow a patient’s tissue for transplants.

At the same time the new legal protections that followed the silicone breast implant debacle have considerably reduced the risk in the medical polymer space. And as a result of all of these factors, the medical polymer business has taken off, with the emergence of new start-ups and plenty of M&A activity.

With all that is happening in this space, NanoMarkets is publishing a report that identifies current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising. As with all NanoMarkets reports in the medical materials field, this report includes a granular eight-year forecast and also profiles key suppliers and analyzes the complete supply chain for medical polymers. For the firms covered we discuss their strategies and needs along with their strengths and weaknesses. Finally, the report provides an analysis of the market for medical polymers in various important country-specific markets.

TABLE OF CONTENTS

Executive Summary
– Opportunities for the Medical Device Market
– Opportunities for the Plastics Industry
– Opportunities for the Healthcare Industry
– Firms and Strategies to Watch in the Medical Polymers Market
– Bayer
– Celanese
– Dow Chemical
– Dow Corning
– DSM
– DuPont
– Eastman Chemical
– Evonik
– Solvay
– Notable Startups

Commercial Trends in Medical Polymers

– Generic Advantages and Disadvantages of Polymers for Medical Applications
– Advantages of Polymers in Medical Applications
– Disadvantages of Polymers in Medical Applications
– Replacement of Metals with Polymers in Medical Devices
– Thermoplastics (PMMA, PLA, PGA, PP, PEEK, Polycarbonates)
– Uses in Medical Applications
– Main Suppliers
– Polyethylene
– Uses in Medical Applications
– Main Suppliers
– Polystyrene
– Uses in Medical Applications
– Main Suppliers
– Polyvinyl Chloride
– Uses in Medical Applications
– Main Suppliers
– Nylon
– Uses in Medical Applications
– Main Suppliers
– Role of Bio plastics in Medical Applications

Applications for Medical Polymers

– Medical Devices and Implants
– Current and Future Use of Polymers
– Regenerative Medicine and Orthopedic Implants
– Contact Lenses and Lens Implants
– Implantable Defibrillators and Related Devices
– Breast Implants
– Conductive Polymer Neural Implants
– Blood Filters
– Other Medical Devices Using Polymers
– Eight-Year Forecast of Polymers in Implants, by Polymer and Implant Type
– Eight-Year Forecast of Polymers in Non-Implantable Devices by Polymer and Device Type Diagnostic Systems
– Type of Polymers Used in Medical Diagnostic Systems
– Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
– Laboratory and Surgical Accessories and Disposables
– Surgical Screws, Nails and Plates
– Catheters and Tubing
– Surgical Gloves
– Sutures and Shunts
– Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type

National Markets and Regulatory Factors
– Generic Policy Issues Raised by Polymer Medical Devices
– Safety Issues Related to Polymer Devices
– Problems of Waste Disposal and Management
– Healthcare Issues and Aging Populations

United States
– Medical Polymers and the Biomaterials Access Assurance Act of 1998
– Impact of “Obama care”
– Role and Impact of the FDA
– Analysis of Market for Medical Polymers in the US
– Eight-Year Forecast for Medical Polymers in the US

Europe
– Role and Impact of European Commission and Other Regulatory Authorities in the EU
– National Regulations and Regulatory Agencies Impacting Medical Polymer Markets
– Analysis of Market for Medical Polymers in Europe
– Eight-Year Forecast for Medical Polymers in Europe

Japan
– National Laws and Regulations Impacting the Medical Polymer Markets
– Analysis of Market for Medical Polymers in Japan
– Eight-Year Forecast for Medical Polymers in Japan

China
– National Laws and Regulations Impacting the Medical Polymer Markets
– Impact of Chinese Industrial Policy on Medical Polymer Markets
– Analysis of Market for Medical Polymers in China
– Eight-Year Forecast for Medical Polymers in China

India
– National Laws and Regulations Impacting the Medical Polymer Markets
– Analysis of Market for Medical Polymers in India
– Eight-Year Forecast for Medical Polymers in India
– Other Notable National Markets for Medical Polymers

About NanoMarkets:

NanoMarkets tracks and analyzes emerging market opportunities created by developments in advanced materials. Visit http://www.nanomarkets.net for a full listing of NanoMarkets’ reports and other services.

Media Contact:
Robert Nolan
NanoMarkets, LC
PO BOX 3840
Glen Allen, VA 23058
(804) 938-0030
rob@nanomarkets.net
http://www.nanomarkets.net